BP000320-PRO-486: Recombinant Human B-Cell Differentiation Antigen CD72 (CD72) Protein
Source: E. coli-derived.
Applications: ELISA; Inhibition Assays; WB.BP000319-PRO-293: Recombinant Human CD68
Source: E. coli-derived.
Purity: > 90.0% as determined by RP-HPLC and SDS-PAGE.BP000318-PRO-483: Recombinant Human CD56
Source: E. coli-derived.
Applications: ELISA; Inhibition Assays; WB.BP000317-PRO-482: Recombinant Human CD45
Source: E. coli-derived.
Applications: ELISA; Inhibition Assays; WB.BP000314-PRO-292: Recombinant Human CD34
Source: E. coli-derived.
Applications: ELISA; Inhibition Assays; WB.BP000313-PRO-471: Recombinant Human CD31
Source: E. coli-derived.
Applications: ELISA; Inhibition Assays; WB.BP000311-PRO-468: Recombinant Human CD2
Source: E. Coli-derived.
Applications: ELISA; Inhibition Assays; WB.BP000307-PRO-472: Recombinant Human CD11b
Source: E.coli-derived.
Applications: ELISA, Inhibition Assays, WB.BP000308-PRO-537: Recombinant Mouse Monocyte Differentiation Antigen CD14 (CD14) Protein
Source: CHO cells-derived.
Applications: ELISA; Inhibition Assays; WB.BP000308-PRO-536: Recombinant Human Monocyte Differentiation Antigen CD14 (CD14) Protein, CHO
Source: CHO-cells-derived.
Biological Activity: Up to 20 ug/ml CD14 inhibit binding of FITC-LPS (0.5 ug/ml) to 6 x 105 CD14+CHO transfectants (FACS).
Purity: > 95% by SDS-PAGE.